Haig, Madeleine, Main, C, Chavez, D and Kanavos, Panos 
ORCID: 0000-0001-9518-3089
(2023)
Navigating the digital health landscape for chronic disease management: a value assessment framework for patient-facing technologies.
Value in Health, 26 (6).
S8 - S8.
ISSN 1098-3015
Abstract
Objectives Digital health technologies (DHTs) have the potential to revolutionize the healthcare industry by optimizing costs and improving the quality and efficiency of care. However, the rapid pace of innovation in the field and the lack of consistent evidence standards make it challenging for decision-makers to effectively evaluate these technologies. To address this challenge, we propose a value framework for assessing DHTs that are used to manage chronic diseases. Methods This framework is based on a Delphi exercise eliciting the preferences of key stakeholders, including patients, physicians, industry representatives, academics and policymakers. Our methodology includes a literature review and primary data collection involving 129 participants from the United States, United Kingdom, and Germany. The data collected was analyzed using STATA to determine inter-group differences and levels of consensus. Results The framework comprises of 33 stable indicators with consensus across six value domains, all rated ‘very important” or ‘important.’ While there was a lack of consensus among stakeholders on certain important aspects such as value-based care models, sustainable systems, and stakeholder engagement, this lack of consensus was primarily due to high rates of neutrality rather than negative evaluations. Supply-side actors and academic experts were the most unstable stakeholder groups and statistically significant disagreement was found between country groups for two indicators. Conclusions Participants suggested indicators that assess aspects of value for DHTs that go not only beyond traditional HTA indicators, but also beyond those included in the study countries’ frameworks. Stakeholders across country groups formed consensus around the importance of data ownership, the ability for patients to input data, and the need for clearly communicated policies. This study reveals a need for a combined regulatory and HTA policy response that updates laws to meet technological innovations, offers a pragmatic approach to evidence standards to assess DHTs, and involves stakeholders to understand and meet their needs.
| Item Type: | Article |
|---|---|
| Divisions: | LSE Health Health Policy |
| Subjects: | R Medicine > RA Public aspects of medicine |
| Date Deposited: | 17 Oct 2024 14:00 |
| Last Modified: | 01 Nov 2024 05:48 |
| URI: | http://eprints.lse.ac.uk/id/eprint/125795 |
Actions (login required)
 |
View Item |
